Karimi Leila, Mansoori Behzad, Shanebandi Dariush, Mohammadi Ali, Aghapour Mahyar, Baradaran Behzad
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Biomed Pharmacother. 2017 Jul;91:121-131. doi: 10.1016/j.biopha.2017.04.060. Epub 2017 Apr 25.
MicroRNAs (miRNAs) are small non-coding RNAs which participate in the post-transcriptional regulation of gene expression. They play important roles in cellular events such as growth and differentiation. Deregulation of miRNAs is frequently evident in human cancers where their aberrant expression is associated with uncontrolled proliferation, metastasis, impaired cell cycle and DNA damage response. The miRNAs are important in cancer as ∼50% of miRNA genes are located in cancer-associated regions such as fragile sites of genome. MiRNA-143 is defined as an important tumor suppressor in a variety of neoplasms including solid tumors and B-cell malignancies. MiRNA-143 is involved in the pathogenesis of cancers by directly targeting several mRNAs such as Bcl-2, KRAS, HK2, DNMT3A, TP53 and MMP-13. In this study, an overview of the miRNA-143 function in different signaling pathways in cancer will be provided.
微小RNA(miRNA)是一类小的非编码RNA,参与基因表达的转录后调控。它们在细胞生长和分化等细胞活动中发挥重要作用。miRNA失调在人类癌症中经常可见,其异常表达与不受控制的增殖、转移、细胞周期受损和DNA损伤反应有关。miRNA在癌症中很重要,因为约50%的miRNA基因位于癌症相关区域,如基因组的脆性位点。MiRNA-143被定义为包括实体瘤和B细胞恶性肿瘤在内的多种肿瘤中的重要肿瘤抑制因子。MiRNA-143通过直接靶向几种mRNA,如Bcl-2、KRAS、HK2、DNMT3A、TP53和MMP-13,参与癌症的发病机制。在本研究中,将概述miRNA-143在癌症不同信号通路中的功能。